前瞻性比较宫颈癌图像引导自适应近距离治疗中计算机断层扫描联合经直肠超声辅助与磁共振成像靶区定义
这项前瞻性比较研究纳入2013年1月至2014年3月接受磁共振图像引导自适应近距离治疗的局部晚期宫颈癌患者25例,在近距离治疗过程中获取经直肠超声图像并记录标志点,将结合临床与经直肠超声信息的CT靶区勾画与金标准磁共振靶区比较。结果显示CT与磁共振的高危临床靶区体积分别为39.1±20 cm³与39±19 cm³(r=0.92,P<.001),各层面靶区宽度和厚度相关性r=0.70-0.80(P<.001),绝对差异<0.5 cm。作者认为结合诊断时磁共振与实时经直肠超声信息的CT靶区及危及器官勾画似乎与金标准磁共振方法相当。
要点
- CT与磁共振高危临床靶区体积分别为39.1±20 cm³与39±19 cm³,r=0.92,P<.001。
- 各层面靶区宽度和厚度CT与磁共振相关性r=0.70-0.80,P<.001,绝对差异<0.5 cm。
- 作者认为结合磁共振与实时经直肠超声信息的CT勾画似乎与磁共振方法相当。
核心结论
- 作者认为,在宫颈癌图像引导自适应近距离治疗中,利用诊断时磁共振与近距离治疗时实时经直肠超声信息进行CT靶区及危及器官勾画,似乎与金标准磁共振方法相当。
研究设计与样本
- 前瞻性比较研究,纳入2013年1月至2014年3月接受磁共振图像引导自适应近距离治疗的局部晚期宫颈癌患者25例,国际妇产科联盟临床分期IIB期11例(44%)、IIIB期14例(56%)。
- 近距离治疗过程中在中心施源器在位时于3个代表性层面获取经直肠超声图像,记录低回声区相对中心施源器的参考点/尺寸(D1-D4);施源器置入后行CT与磁共振近距离治疗计划成像;在结合临床与经直肠超声所见的基础上于CT扫描勾画高危临床靶区,并与金标准磁共振靶区方法比较。
主要发现
- CT与磁共振高危临床靶区平均(±标准差)体积分别为39.1(±20)cm³与39(±19)cm³(r=0.92;P<.001)。
- CT与磁共振高危临床靶区尺寸(宽度和厚度)在各层面均呈显著相关(r=0.70-0.80;P<.001),CT与磁共振靶区尺寸的绝对差异<0.5 cm。
- 对于内侧和外侧宫旁侵犯患者,CT与磁共振之间呈强相关(P<.05),与近距离治疗时无宫旁病变者相比。
- 不论宫旁是否受侵,CT与磁共振勾画的高危临床靶区宽度在各层面的平均差异仅为0.1至0.4 cm。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although magnetic resonance imaging (MRI) represents the gold standard for image guided adaptive brachytherapy (IGABT) for cervical cancer, the majority of brachytherapy (BT) continues to be guided by computed tomography (CT). However, CT seems to overestimate the target-volume definition, and the potential of transrectal ultrasonography (TRUS) needs further evaluation. This prospective, comparative study aimed to evaluate CT-based target contouring with the incorporation of TRUS during BT. METHODS AND MATERIALS: Patients with locally advanced cervical cancer undergoing magnetic resonance IGABT between January 2013 and March 2014 were included. During the BT procedure, TRUS imaging with central tandem in situ was acquired at 3 representative levels. Reference points/dimensions (D1-D4) of the hypoechoic region on TRUS images with respect to the central tandem were recorded. CT and magnetic resonance BT planning imaging was performed after BT application. The high-risk clinical target volume (HR-CTV) was contoured on CT scans with incorporation of clinical and TRUS imaging findings and was compared with the gold standard MRI-based target approach. RESULTS: The image sets of 25 patients (International Federation of Gynecology and Obstetrics clinical stage IIB [11; 44%] and IIIB [14; 56%]) were evaluable. The mean (±standard deviation) volumes of HR-CTV on CT and MRI imaging were 39.1 (±20) cm³ and 39 (±19) cm³, respectively (r = 0.92; P < .001). A significant correlation was found between the HR-CTV dimensions (width and thickness) of CT and MRI scans at various levels (r = 0.70-0.80; P < .001). In addition, the absolute differences in target dimensions between CT and MRI were <0.5 cm. A strong correlation was seen between CT and MRI for patients with medial and lateral parametrial invasion (P < .05) compared with no parametrial disease at BT. Furthermore, the mean differences in HR-CTV width between CT and MRI contours at various levels, irrespective of parametrial involvement, was only 0.1 to 0.4 cm. CONCLUSIONS: This study suggests that a CT-based target and organ-at-risk delineation using MRI at diagnosis and real-time TRUS information during BT seems comparable with the gold standard MRI-based approach in IGABT for cervical cancer.
引用
- Mahantshetty U, Naga Ch P, Khadanga CR, et al. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers. Int J Radiat Oncol Biol Phys. 2018. PMID: 30146092. doi:10.1016/j.ijrobp.2018.05.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。